LBA86 Androgen receptor pathway inhibitors or taxanes for patients with metastatic castration-resistant prostate cancer: A direct comparison in ProBio, a randomized, outcome-adaptive, biomarker-driven platform trial
Autor: | Grönberg, H., Lindberg, J., De Laere, B., Crippa, A., Discacciati, A., Karlsson, C.T., Ullén, A., Jänes, E., Mortezavi, A., Ost, P., Enblad, G., Oldenburg, J., Sandzén, J., Pettersson, L., Vigmostad, M.N., Hjälm-Eriksson, M.E., Olsson, M., Schatteman, P., Ghysel, C., Eklund, M. |
---|---|
Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S1327-S1327 |
Databáze: | ScienceDirect |
Externí odkaz: |